Website intended for a NZ health professional readership
1. Emin Evren Özcan and Bülent Görenek What we have learned from the European Heart Rhythm Association consensus document on device-detected subclinical atrial tachyarrhythmias Anatol J Cardiol 2018 Feb;19(2):137–139
2. Page RL1, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994 Jan;89(1):224–7
3. Healey JS et al Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012 Jan 12;366(2):120-9.
4. Botto GL et al Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. Cardiovasc Electrophysiol 2009 Mar;20(3):241-8. Epub 2008 Oct 30.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
